SOAT1 and Sepsis: Therefore, we investigated the impact of sepsis and/or baricitinib on the activation of the JAK/STAT pathway (the target for the drug) and on further inflammatory pathways known to play a crucial role in the pathophysiology of sepsis-induced cardiac (and multi-organ) dysfunction, namely NF-κB and NLRP3 inflammasome.